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Abstract
 
Toll-like receptors (TLRs) mediate recognition of a wide range of microbial products includ-
ing lipopolysaccharides, lipoproteins, flagellin, and bacterial DNA, and signaling through
TLRs leads to the production of inflammatory mediators. In addition to TLRs, many other
surface receptors have been proposed to participate in innate immunity and microbial recog-
nition, and signaling through some of these receptors is likely to cooperate with TLR signal-
ing in defining inflammatory responses. In this report we have examined how dectin-1, a lec-
tin family receptor for 
 
 
 
-glucans, collaborates with TLRs in recognizing microbes. Dectin-1,
which is expressed at low levels on macrophages and high levels on dendritic cells, contains an
immunoreceptor tyrosine-based activation motif–like signaling motif that is tyrosine phos-
phorylated upon activation. The receptor is recruited to phagosomes containing zymosan par-
ticles but not to phagosomes containing immunoglobulin G–opsonized particles. Dectin-1
expression enhances TLR-mediated activation of nuclear factor 
 
 
 
B by 
 
 
 
-glucan–containing
particles, and in macrophages and dendritic cells dectin-1 and TLRs are synergistic in mediat-
ing production of cytokines such as interleukin 12 and tumor necrosis factor 
 
 
 
. Additionally,
dectin-1 triggers production of reactive oxygen species, an inflammatory response that is
primed by TLR activation. The data demonstrate that collaborative recognition of distinct
microbial components by different classes of innate immune receptors is crucial in orchestrat-
ing inflammatory responses.
Key words: lectin • ITAM • zymosan • dendritic cell • macrophage
 
Introduction
 
The innate immune system uses a wide variety of micro-
bial recognition receptors including Toll-like receptors
(TLRs),
 
* 
 
lectins, scavenger receptors, and integrins to
identify potential pathogens (1). Microbial recognition by
phagocytes triggers phagocytosis, induction of microbial
killing, production of inflammatory cytokines and chemo-
kines, and initiates the development of adaptive immunity.
All microbes do not induce these responses equally, and the
constellation of innate immune recognition receptors acti-
vated by a given microbe likely defines the nature of the
effector response. Activation of one response such as phago-
cytosis does not necessarily require activation of other re-
sponses. For example, phagocytosis of some particles such
 
as apoptotic cells is noninflammatory (2). Similarly, in-
flammatory signaling does not require initiation of phago-
cytosis because many soluble microbial products such as
LPS and bacterial lipoproteins are potent inducers of in-
flammation (3–6). Nevertheless, the fact that complex mi-
crobial surfaces present ligands for phagocytic as well as
proinflammatory receptors and the fact that these receptors
share many intracellular signaling molecules suggests that
these different classes of receptors interact with each other
in functionally important ways (1). As a model for eluci-
dating the consequences of these interactions, we have ex-
amined the role for receptor cooperation in phagocyte re-
sponses to zymosan.
Zymosan is a cell wall preparation of 
 
Saccharomyces cerevi-
siae
 
 that has been used for over 50 yr as a model phagocytic
 
Address correspondence to David M. Underhill, Institute for Systems Bi-
ology, 1441 N. 34th
 
 
 
Street, Seattle, WA 98103. Phone: 206-732-1374;
Fax: 206-732-1299; E-mail: dunderhill@systemsbiology.org
 
*
 
Abbreviations used in this paper:
 
 BMDC, bone marrow–derived den-
dritic cell; ITAM, immunoreceptor tyrosine-based activation motif; NF,
nuclear factor; ROS, reactive oxygen species; TLR, Toll-like receptor.T
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and inflammatory stimulus both in vivo and in vitro (7, 8).
The preparation is composed primarily of 
 
 
 
-glucans, man-
nans, mannoproteins, and chitin, and each of these com-
pounds has been implicated in recognition of yeast by the
innate immune system (1, 8–10). In myeloid cells zymosan
stimulates phagocytosis, the production of inflammatory
cytokines and chemokines, production of reactive oxygen
and nitrogen species, and is a potent adjuvant in stimulating
adaptive immune responses. We have previously observed
that zymosan-induced inflammatory cytokine production
by macrophages is mediated by TLRs and does not require
particle internalization (11, 12).
TLRs are a family of 10 innate immune recognition re-
ceptors that are required for detection of a broad range of
microbial products including LPS, flagellin, and bacterial
lipoproteins (3–6). Several TLR family members are ac-
tively recruited to phagosomes during microbe internaliza-
tion where they sample the contents of the phagosomes to
determine the nature of the microbes being ingested.
Thus, TLR1, TLR2, and TLR6 are all recruited to
phagosomes containing zymosan particles (11, 13). We
have previously demonstrated that both TLR2 and TLR6
are required for activation of nuclear factor (NF)-
 
 
 
B and
production of inflammatory cytokines such as TNF-
 
  
 
by
zymosan particles, although TLR activation is not re-
quired for recruitment to phagosomes because TLRs are
also recruited to phagosomes during internalization of
IgG-opsonized sheep erythrocytes by Fc receptors, a pro-
cess that does not stimulate TLRs (11, 13). Thus, TLRs
are poised to recognize ligands should they be present in
the phagosome. TLR activation is not sufficient to trigger
phagocytosis because expression of TLR2 in nonphago-
cytic cells does not confer on the cells the ability to inter-
nalize zymosan (11).
A variety of receptors including those for mannans and
 
 
 
-glucans have been implicated in recognition and phago-
cytosis of zymosan particles (1). Brown and Gordon (14)
and Brown et al. (15) recently identified a C-type lectin
called dectin-1 that is expressed on monocytes, macro-
phages, and dendritic cells as a phagocytic receptor for
 
 
 
-glucan containing particles including zymosan and 
 
Can-
dida albicans
 
. The receptor is related to a variety of lectin-
type NK receptors, is encoded in the NK gene complex,
and may function as a dendritic cell coreceptor for T cell
activation by binding an unidentified target on T cells via a
site distinct from the 
 
 
 
-glucan binding site (16–20). The
extracellular COOH terminus of this type 2 transmem-
brane protein contains a single C-type lectin domain (17).
The short intracellular NH
 
2 
 
terminus contains an immu-
noreceptor tyrosine-based activation motif (ITAM)-like
signaling motif, a structure found on a variety of proin-
flammatory signaling receptors including Fc receptors, T
cell receptors, and NK receptors (21, 22), suggesting that
dectin-1 might play an important role in inflammatory re-
sponses to 
 
 
 
-glucan–containing particles in addition to its
role in phagocytosis. Therefore, we examined the capacity
for dectin-1 to cooperate with TLR2 in defining inflam-
matory responses to zymosan.
 
Materials and Methods
 
Reagents and Plasmids.
 
Zymosan (Sigma-Aldrich), LPS (List),
and the synthetic lipopeptide PAM
 
3
 
CSK
 
4 
 
(EMC Microcollec-
tions) were prepared as previously described (11). FITC-con-
jugated anti-V5 antibody (Invitrogen), unlabeled V5 epitope
antibody (P-K; Serotec), anti–sheep red blood cell antibody (In-
tercell), and sheep red blood cells (ICN Biomedicals/Cappel)
were used as previously described (12, 13). Murine IL-12 and
TNF-
 
  
 
ELISA kits were purchased from R&D Systems and the
sensitivity of detection was 5 pg/ml for both. Laminarin (Sigma-
Aldrich) was prepared as a 10-mg/ml stock solution, sterile
filtered, and stored frozen until use. Depleted zymosan was pre-
pared by boiling 250 
 
 
 
g zymosan in 1 ml 10 M sodium hydrox-
ide for 30 min and washing three times with sterile PBS.
Murine TLR2 and CD14 expression vectors have been previ-
ously described (11). The murine dectin-1 expression vector was
constructed by amplifying the full coding region of murine dec-
tin-1 (sequence data available from GenBank/EMBL/DDBJ
under accession no. AF262985) from RAW 264.7 cDNA and
cloning the resulting fragment into pEF6/V5-HIS-TOPO (Invit-
rogen), thus adding a V5-HIS epitope tag to the COOH termi-
nus of the expressed protein. Tyrosine 15 was mutated to serine
(pEF6-DectinY15S) and the NH
 
2
 
-terminal 38 amino acids were
replaced with a new ATG start codon (pEF6-Dectin
 
 
 
38) by
PCR. The dectin-1 coding region was fused to the 3
 
  
 
end of
eGFP (CLONTECH Laboratories, Inc.) by PCR. The identities
of all expression vectors were confirmed by sequencing. Mutant
versions of dectin-1 were expressed in HEK 293 and RAW
264.7 cells equally as efficiently as the epitope-tagged wild-type
protein and were expressed at the cell surface in a manner indis-
tinguishable from the wild-type protein (unpublished data).
 
Mice.
 
MyD88
 
    
 
mice (129/SvJ
 
  
 
C57Bl/6 background; ref-
erence 23) were backcrossed for six generations with C57Bl/6
mice. Mice from the F3 or F6 generation were used and were
compared with littermate controls (MyD88
 
   
 
). TLR2
 
    
 
mice
(129/SvJ
 
  
 
C57Bl/6 background; reference 24) were backcrossed
for two generations with C57Bl/6 mice. Mac-1 (CD11b)
 
    
 
and
C57Bl/6 mice were purchased from The Jackson Laboratory.
 
Cell Lines.
 
HEK 293 cells (American Type Culture Collec-
tion [ATCC] no. CRL-1573) were maintained in DMEM (In-
vitrogen) and the mouse macrophage cell line RAW 264.7 cells
(ATCC no. TIB-71) was maintained in RPMI (Invitrogen).
Both media were made complete with 10% heat-inactivated fetal
bovine serum (Hyclone), 100 U/ml penicillin, 100 
 
 
 
g/ml strep-
tomycin, and 2 mM 
 
l
 
-glutamine (GIBCO BRL). RAW cells
transfected with an NF-
 
 
 
B luciferase reporter have been de-
scribed (25). The coding regions for mouse wild-type and trun-
cated dectin-1 (V5-HIS tagged) were cloned into pFB-Neo
(Stratagene), allowing for expression of dectin-1 and neomycin
resistance from single polycystronic mRNAs. These plasmids
were transfected into RAW 264.7 cells by electroporation (13) or
Effectene (QIAGEN), and populations of G418- (0.4 mg/ml; In-
vitrogen) resistant cells were generated. Several populations ex-
pressing wild-type and mutant dectin-1 were recovered and data
from one population of each are presented. The remaining popu-
lations responded to zymosan in manners consistent with the data
presented and proportional to their levels of dectin-1 expression.
Phagocytosis was quantified as previously described (11).
 
Primary Cell Culture.
 
Bone marrow–derived macrophages
were prepared by 7 d of culture in 20% L929 cell–conditioned
media. Phagocytosis was quantified as previously described (11).
Bone marrow–derived dendritic cells were cultured using a pre-
viously described method (26) with minor alterations. Bone mar-T
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row was collected from femurs of adult mice and resuspended in
complete RPMI containing 10 ng/ml GM-CSF (R&D Systems)
and 20 ng/ml IL-4 (R&D Systems). After 2 d in culture, media
and nonadherent cells were aspirated and replaced with fresh me-
dia, media was replaced again after 4 d, and assays were per-
formed on day 5. Purity of dendritic cell preparations was assayed
by flow cytometry using the following panel of antibodies (all
from BD Biosciences, except where noted), and found to be at
least 75% pure): anti–CD11c-FITC, anti–CD11b-FITC, anti–
CD40-biotin, anti–GR-1–PE, anti–CD14-FITC, anti–F4/80-bi-
otin (Caltag Laboratories). Dendritic cell cultures were found to
be of the immature phenotype by low level staining with anti–I-
A
 
b
 
–biotin, anti–B7-1–biotin, and Streptavidin-PE (Caltag Labo-
ratories) compared with activated controls. Unelicited peritoneal
macrophages were isolated by peritoneal lavage and plated di-
rectly into 96-well luminometer plates (Costar) in complete
DMEM and incubated overnight. Nonadherent cells were re-
moved and the cells were placed in 100 
 
 
 
l fresh media containing
50 U/ml recombinant interferon 
 
  
 
(PeproTech) for 4 h before
use in the chemiluminescence oxidase assay described below.
 
Real-Time PCR Analysis.
 
RAW 264.7 cells were plated at
0.5 
 
  
 
10
 
6 
 
per 1 ml complete RPMI for 24 h before start of assay.
Total RNA was prepared with RNeasy columns (QIAGEN) us-
ing the manufacturer’s protocols. Synthesis of cDNA was com-
pleted with MMLV Reverse Transcriptase (Promega) according
to the manufacturer’s recommendations and primed with oligo
d(T) (Promega). Quantitative real-time PCR was performed on
an ABI 7700 (Applied Biosystems) using TaqMan Universal PCR
Master Mix (Applied Biosystems). Probes (IDT) labeled with 5
 
 
 
FAM and 3
 
  
 
TAMRA modifications were used at a final concen-
tration of 0.9 mM, and primers were used at 0.2 mM (GIBCO
BRL). The PCR program was as follows: 50
 
 
 
C for 2 min and
95
 
 
 
C for 10 min (95
 
 
 
C for 15 s and 60
 
 
 
C for 1 min) for 40 cycles.
All data were normalized to EF1
 
  
 
expression in the same cDNA
set. Data is presented in relative mRNA units and represents the
average of at least three values 
 
  
 
standard deviation. Each experi-
ment was performed independently at least three times and the
results of one representative experiment are shown. Sequences
are as follows: IL-12 p40 probe: GGAAACACATGCCCACT-
TGCTGCA, forward primer: GCTCAGGA-
TCGCTATTACAATTCC, reverse primer: TCTTCCTTAAT-
GTCTTCCACTTTTCTT; TNF-
 
  
 
probe: TCAGCCTCT-
TCTCATTCCTGCTTG, forward primer: TCCAGGCGGT-
GCCTATGT, reverse primer: CACCCCGAAGTTCAGTAG-
ACAGA; and EF1
 
  
 
probe: CACCTGAGCAGTGAAGCC-
AGCTGCT, forward primer: GCAAAAACGACCCACCA-
ATG, reverse primer: GGCCTGGATGGTTCAGGATA.
 
Luciferase Assays.
 
HEK 293 cells were transfected by calcium
phosphate precipitation in 96-well plates. Each well received
250 ng ELAM luciferase reporter and 125 ng TK-RL
(Promega) transfection control reporter together with 250 ng
TLR2, dectin-1, CD14 expression vectors, or pEF6 vector con-
trol as indicated for a total of 875 ng DNA. Cells were trans-
fected overnight and stimulated with the indicated reagents for
4 h. The cells were lysed and firefly and Renilla luciferase activ-
ities were determined using the Dual Luciferase Assay kit
(Promega). Luciferase activity is expressed as the ratio of the
ELAM luciferase (firefly) activity to the TK-RL (Renilla) activ-
ity. Assays were performed in triplicate with standard deviations
indicated and are representative of at least three independent
experiments.
 
Assay of Luminol-enhanced Chemiluminescence.
 
Production of
reactive oxygen species (ROS) was assayed by luminol-enhanced
 
chemiluminescence (27). RAW 264.7 cells were suspended in
culture medium at 400,000 cells/ml, warmed to 37
 
 
 
C in water
bath for 30 min, and then 100-
 
 
 
l aliquots were placed in a 96-
well luminometer plate (Costar). 100 
 
 
 
l medium containing 100
 
 
 
M luminol (Fluka) with or without zymosan and laminarin at
the indicated concentrations was added. Chemiluminescence was
measured at 2.5-min intervals. Luminescence is expressed as rela-
tive luciferase units/minute/1,000 cells and was not reduced in
the presence of inhibitors of inducible nitric oxide synthase (un-
published data).
 
Immunoprecipitations and Phosphotyrosine Analysis.
 
RAW cells
expressing epitope-tagged wild-type dectin-1 were stimulated in
6-well dishes as indicated for 15 min in the presence of 1 mM so-
dium orthovanadate. The cells were lysed in 250 
 
 
 
l lysis buffer I
(1% SDS, 10 mM Tris, 0.2 mM sodium orthovanadate, pH 7.4,
with protease inhibitors) and insoluble material was pelleted. 750
 
 
 
l lysis buffer II (1% Triton X-100, 50 mM NaCl, 10 mM Tris,
0.2 mM sodium orthovanadate, pH 7.4, with protease inhibitors)
was added together with 15 
 
 
 
l PY20 agarose beads (Zymed Lab-
oratories). The mixture was incubated for 2 h at 4
 
 
 
C, the beads
were washed twice with lysis buffer II, and tyrosine phosphory-
lated proteins were separated by SDS-PAGE. Recovery of
epitope-tagged dectin-1 was determined by blotting with anti-V5
antibody (P-K; Serotec).
 
Results
 
Dectin-1 and TLR2 Collaboration.
 
We have previously
observed that expression of inhibitory forms of TLR2,
TLR6, and MyD88 (an adaptor molecule required for TLR
signaling; references 4, 5, and 28) do not inhibit recognition
and phagocytosis of zymosan by macrophages (11, 13). We
have extended these observations using macrophages from
TLR2– and MyD88-deficient mice and examining the pro-
duction of ROS. Phagocytosis of unopsonized zymosan is
unaffected in bone marrow–derived macrophages from
mice deficient in TLR2 or MyD88, indicating that addi-
tional receptor(s) recognize the particle and trigger intra-
cellular signaling for phagocytosis (Fig. 1, a and b).
Macrophages from mice lacking MyD88 fail to produce in-
flammatory cytokines such as TNF-
 
  
 
in response to the
pure TLR2 stimulus, PAM
 
3
 
CSK
 
4 
 
lipopeptide (a synthetic
tri-palmitoylated bacterial lipopeptide; reference 13), or in
response to the more complex TLR2 stimulus zymosan
(Fig. 1 c). Zymosan particles trigger the production of ROS
in murine macrophages and although TLR activation is re-
quired for cytokine production, TLR2
 
    
 
and MyD88
 
   
 
macrophages still produce ROS in response to zymosan
(Fig. 1 d). TLR stimulation alone is not sufficient to induce
ROS because PAM
 
3
 
CSK
 
4 
 
lipopeptide and LPS fail to trig-
ger ROS production in a mouse macrophage cell line (Fig.
1 e) or in primary peritoneal macrophages (unpublished
data). Thus, recognition through receptors independent of
TLRs mediates ROS production and phagocytosis.
It is not clear whether in the presence of TLR-mediated
inflammatory signaling additional receptors contribute to
modulation of gene expression. Therefore, we explored
whether recognition by a phagocytic receptor for zymosan
(dectin-1) could contribute to TLR-mediated signaling. As
we and others have previously observed, HEK 293 cellsT
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(that do not normally express TLR2 or respond to TLR2
stimuli) transiently transfected with TLR2 and an NF-
 
 
 
B
luciferase reporter plasmid respond strongly to the soluble
TLR2 stimulus PAM
 
3
 
CSK
 
4 
 
lipopeptide. However, the
cells respond poorly to zymosan, suggesting that additional
recognition molecules are required for efficient TLR2–
mediated detection of zymosan (Fig. 2 a). Coexpression of
dectin-1 (that is not endogenously expressed by HEK 293
cells; reference 16) enhanced TLR2–mediated recognition
of zymosan to levels comparable to stimulation by the sol-
uble lipopeptide (Fig. 2 a). Although expression of dectin-1
alone in HEK 293 cells conferred the ability to phagocy-
tose zymosan (unpublished data), it did not confer NF-
 
 
 
B
activation by zymosan in this system (Fig. 2 a), suggesting
that dectin-1 signaling alone is not sufficient to activate
NF-
 
 
 
B and associated downstream inflammatory re-
sponses. Dectin-1–enhanced signaling was clearly depen-
dent on TLR2 activation because expression of a sig-
naling-deficient mutant of TLR2, TLR2-P681H (11),
blocked NF-
 
 
 
B activation (Fig. 2 a). Dectin-1 signaling is
required for enhanced TLR2 responses because mutation
of dectin-1 either by truncation of the intracellular amino
terminal 38 acids (Dectin-
 
 
 
38) or by substitution of ty-
rosine 15 (in the ITAM-like motif) to serine (DectinY15S)
abrogated the enhancement (Fig. 2 b). Dectin-enhanced
signaling was dependent on recognition of 
 
 
 
-glucan on
the particle because laminarin (a soluble 
 
 
 
-glucan from the
brown seaweed 
 
Laminaria digitata
 
) completely blocked the
enhancement (Fig. 2 c). Although we have observed dec-
tin-1 and TLR2 enriched together on phagosomes con-
taining zymosan, we have not detected direct physical
interactions between the receptors, suggesting that cooper-
ation occurs by parallel activation (unpublished data).
We have previously observed that CD14 (a soluble or
GPI-linked protein) can facilitate TLR2–mediated inflam-
matory responses to zymosan (11), so we compared the re-
quirement for 
 
 
 
-glucan recognition by CD14 and dectin-1.
Laminarin had no effect on intracellular signaling by TLR2
coexpressed with CD14 (Fig. 2 c), demonstrating that nei-
ther CD14 nor TLR2 directly recognizes 
 
 
 
-glucan. Taken
together, these observations demonstrate that dectin-1 en-
hances TLR signaling in response to 
 
 
 
-glucan–containing
particulate stimuli.
 
Dectin-1 Enhances Cytokine Production in Macrophages.
 
To examine the role of 
 
 
 
-glucan recognition in zymosan-
induced inflammatory signaling in macrophages, we estab-
lished a model system using the RAW 264.7 (RAW)
mouse macrophage cell line. RAW cells express surface
CD14, low levels of mRNA for dectin-1, and bind and in-
ternalize zymosan. We generated a stable population of
cells overexpressing an epitope-tagged dectin-1. By real-
time PCR, these cells express 34-fold (
 
 
 
3) more dectin-1
mRNA than the parental cells. As demonstrated by flow
cytometry, the population uniformly expresses epitope-
tagged dectin-1 (Fig. 3 a) and immunofluorescence micros-
copy revealed that the receptor is expressed evenly at the
cell surface and is also found in some intracellular compart-
ments (Fig. 3 c).
Although dectin-1 expression in nonphagocytic cells such
as NIH3T3 cells (14) or HEK 293 cells (unpublished data) is
sufficient to confer the ability to internalize zymosan parti-
cles, phagocytosis of fluorescently labeled zymosan was only
mildly enhanced in RAW cells overexpressing dectin-1
(Fig. 3 b). Parental RAW cells bind and internalize zymosan
efficiently and this internalization is not substantially inhib-
ited by soluble 
 
 
 
-glucans (unpublished data), indicating that
in these cells receptors in addition to 
 
 
 
-glucan receptors
mediate zymosan phagocytosis. We have previously re-
ported that TLR2 is recruited to phagosomes containing zy-
mosan particles and that this recruitment does not require
Figure 1. Zymosan engages receptors on
macrophages other than TLRs. (a and b)
Bone marrow–derived macrophages from
wild-type, TLR2   , or MyD88    mice
were incubated with tetramethylrhodamine
isothiocyanate–labeled zymosan for 15 min.
Phagocytosis was visualized by immunoflu-
orescence microscopy (a) and quantified by
flow cytometry (b). (c) Bone marrow mac-
rophages from MyD88     or wild-type
mice were stimulated with 100  g/ml zy-
mosan or 100 ng/ml PAM3CSK4 lipopep-
tide for 4 h and TNF-  mRNA production
was measured by quantitative real-time
PCR. (d and e) Production of ROS was
assayed by luminol-enhanced chemilumi-
nescence in peritoneal macrophages from
wild-type, TLR2   , or MyD88    mice
(d) stimulated with 200  g/ml zymosan or
in RAW 264.7 macrophages (e) stimulated
with 100  g/ml zymosan, 100 ng/ml LPS,
or 100 ng/ml PAM3CSK4 lipopeptide.T
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ligand binding because TLR2 is also recruited to phago-
somes containing IgG-opsonized particles (13). Therefore,
we examined whether dectin-1 is similarly recruited to
phagosomes. Dectin-1 is strongly enriched on zymosan
phagosomes (Fig. 3 d), but unlike TLR2, dectin-1 is not
significantly recruited to phagosomes containing IgG-
opsonized particles (Fig. 3 e). Further, dectin-1 is not signif-
icantly enhanced on IgG-opsonized particles after stimula-
tion of TLR2 with PAM
 
3CSK4 lipopeptide, nor is dectin-1
enriched on phagosomes containing Staphylococcus aureus
(unpublished data), supporting a model in which  -glucan
binding is required for dectin-1 recruitment to phagosomes.
The cytoplasmic tail of dectin-1 contains two tyrosines
and these amino acids are arranged in a sequence similar to
the consensus sequence for an ITAM motif. Therefore, we
examined whether dectin-1 is tyrosine phosphorylated
upon stimulation with zymosan. RAW cells expressing V5
epitope–tagged dectin-1 were stimulated with zymosan, ly-
sates were prepared, and tyrosine phosphorylated proteins
were immunoprecipitated. Dectin-1 was detected by im-
munoblotting in all lysates but was recovered by antiphos-
photyrosine immunoprecipitation only after binding zymo-
san (Fig. 3 f). Tyrosine phosphorylation of dectin-1 was
blocked by the addition of soluble laminarin, demonstrat-
ing that binding to particulate  -glucans triggers tyrosine
phosphorylation of the ITAM-like motif in dectin-1 (Fig. 3
f). Thus, these cells provide a model for studying the con-
tribution of dectin-1 to zymosan-induced inflammatory re-
sponses in macrophages.
We stimulated control RAW cells and cells overex-
pressing dectin-1 with zymosan, PAM3CSK4 lipopeptide,
or LPS and measured cytokine production by ELISA.
Dectin-1 expression enhanced TNF-  expression in re-
sponse to zymosan but not in response to the other TLR
stimuli, and this enhancement was blocked by soluble lam-
inarin (Fig. 3 g). In contrast to TNF- , RAW cells do not
produce detectable amounts of IL-12 in response to zymo-
san or PAM3CSK4 lipopeptide (Fig. 3, h and i). Dectin-1
expression facilitated zymosan-induced IL-12 p40 pro-
duction as measured by ELISA (Fig. 3 h) and quantitative
real-time PCR (Fig. 3 i) whereas lipopeptide and LPS re-
sponses were not affected. Thus, dectin-1 expression spe-
cifically enhances zymosan-induced cytokine production
in macrophages.
To separate the dectin-1– and TLR2–activating compo-
nents of zymosan, we treated zymosan with hot alkali to
remove all of its TLR-stimulating properties. In a very
sensitive assay for NF- B activation in RAW cells (25),
this depleted zymosan had no activity compared with un-
treated zymosan (Fig. 4 a), although these macrophages still
bound and internalized the particles (unpublished data).
The depleted zymosan particles were still specifically rec-
ognized by dectin-1. GFP-tagged dectin-1 expressed in
HEK 293 cells was found at the cell surface (Fig. 4 b, left)
and bound to and internalized depleted zymosan particles
(Fig. 4 b, right). Untransfected HEK 293 cells do not bind
or internalize depleted zymosan (unpublished data). In ad-
dition, these particles trigger phosphorylation of dectin-1
in RAW cells overexpressing dectin-1 (Fig. 4 c). Thus, de-
pleted zymosan activates dectin-1 without stimulating
TLRs. PAM3CSK4 lipopeptide alone fails to induce phos-
phorylation on dectin-1 and also fails to enhance dectin-1
phosphorylation in response to depleted zymosan particles
(Fig. 4 c), suggesting that TLR2 activation does not play a
role in the tyrosine phosphorylation of dectin-1. There-
fore, we treated RAW cells or RAW cells overexpressing
dectin-1 with depleted zymosan alone or together with
PAM3CSK4 lipopeptide and measured induction of IL-12
p40 mRNA (Fig. 4 d). Although neither PAM3CSK4 li-
popeptide nor depleted zymosan induced significant
amounts of IL-12, together the stimuli were strongly syn-
ergistic. The synergy was amplified in cells overexpressing
dectin-1 and was blocked by laminarin. Similar results
were obtained for the induction of TNF-  mRNA (un-
published data). Taken together, these data demonstrate
that signaling by dectin-1 in macrophages collaborates with
TLR signaling to shape inflammatory responses to  -glu-
can–containing particles.
Figure 2. Dectin-1 and TLR2 collaborate in zymosan recognition by
HEK 293 cells. (a and b) Activation of NF- B (ELAM luciferase) was
measured in HEK 293 cells transiently transfected with the indicated ex-
pression vectors and stimulated with 100  g/ml zymosan or 100 ng/ml
PAM3CSK4 lipopeptide for 4 h. (c) Activation of NF- B was measured in
HEK 293 cells transfected with expression vectors for TLR2 (together
with either CD14 or dectin-1) and stimulated with 100  g/ml zymosan
in the indicated concentrations of laminarin.T
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Dectin-1 Enhances Cytokine Production in Dendritic Cells.
The observation that amplified dectin-1 expression in-
creases TLR-mediated responses in a macrophage cell line
suggested that in vivo dectin-1 might be especially impor-
tant for inflammatory responses in dendritic cells that natu-
rally expresses high levels of dectin-1 (17, 18, 20). Mouse
Figure 3. Zymosan triggers activation of
dectin-1 and enhanced inflammatory responses
in mouse macrophages. (a) V5 epitope–tagged
dectin-1 expression was measured by flow cy-
tometry in RAW cells stably overexpressing
wild-type dectin-1 (green line) and in control
RAW cells (shaded). (b) Control cells (black
line) and cells overexpressing dectin-1 (green
line) were incubated with tetramethylrho-
damine isothiocyanate zymosan for 1 h and
phagocytosis was measured by flow cytometry
and compared with unfed control cells (shaded).
(c–e) The cellular distribution of epitope-
tagged dectin-1 (green) was examined by im-
munofluorescence microscopy in resting cells
(c), cells fed zymosan (red) for 5 min (d), or in
cells fed IgG-opsonized sheep red blood cells
(red) for 5 min (e). (f) Cells expressing V5-
tagged dectin-1 were fed 100  g/ml zymosan
for 15 min in the presence or absence of 50  g/
ml laminarin, total cell lysates were prepared,
and the protein was detected in all lysates by
immunoblot using an antibody for the tag (bot-
tom). Tyrosine-phosphorylated proteins were
immunoprecipitated from the lysates and recov-
ery of dectin-1 was analyzed by immunoblot
(top). (g and h) Induction of inflammatory re-
sponses was measured by ELISA in control
RAW cells and cells overexpressing dectin-1
stimulated with 100  g/ml zymosan (zym), 100
ng/ml PAM3CSK4  lipopeptide (Lip), or 100
ng/ml LPS for 4 (g, TNF- ) or 24 h (h, IL-12 p40) in the presence or absence of 500  g/ml laminarin as indicated. N.D., none detected. (i) Induction
of IL-12 p40 mRNA was measured by quantitative real-time PCR in cells stimulated for 4 h as in g.
Figure 4. Zymosan depleted of its TLR
stimulatory activity synergizes with a TLR2
agonist through activation of dectin-1. (a)
RAW cells stably transfected with an NF- B
luciferase reporter (ELAM luciferase) were
stimulated for 4 h with the indicated concen-
trations of zymosan ( ) or depleted zymosan
( ), and luciferase activity was measured. (b)
HEK 293 cells were transiently transfected
with dectin-1 fused to green fluorescent pro-
tein at the receptor’s intracellular amino ter-
minus and dectin-1 localization was visual-
ized before (left) and after (right) exposure to
depleted zymosan. (c) Cells expressing V5-
tagged dectin-1 were stimulated with 100
 g/ml zymosan, 100  g/ml depleted zymo-
san, or PAM3CSK4 lipopeptide as indicated
for 15 min in the presence or absence of 50
 g/ml laminarin. Total cell lysates were pre-
pared and the protein was detected by im-
munoblot using an antibody for the tag
(bottom). Tyrosine-phosphorylated proteins
were immunoprecipitated from the lysates
and recovery of dectin-1 was analyzed by
immunoblot (top). (d) IL-12 p40 mRNA
production was measured by quantitative
real-time PCR in control RAW cells and
cells overexpressing dectin-1 stimulated for
4 h with 100 ng/ml PAM3CSK4 lipopeptide
or 100  g/ml depleted zymosan in the pres-
ence or absence of 500  g/ml laminarin.T
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bone marrow–derived dendritic cells (BMDCs) express
127-fold ( 34) more dectin-1 mRNA than RAW cells as
measured by quantitative real-time PCR, and we observed
that dendritic cell responses to zymosan including induc-
tion of IL-12 and TNF-  were reduced in the presence of
soluble  -glucan (Fig. 5, a and b). Although  -glucan rec-
ognition was very important for BMDC responses to zy-
mosan, these responses were still dependent on TLR sig-
naling because they were abrogated in BMDCs from
MyD88-deficient mice (Fig. 5 b). Although the doses of
zymosan (100  g/ml) and PAM3CSK4 lipopeptide (100
ng/ml) used are maximal for induction of inflammatory re-
sponses in macrophages, in BMDCs zymosan is a much
stronger activator of both TNF-   and IL-12 than
PAM3CSK4 lipopeptide, suggesting especially strong coop-
eration between TLR2 and  -glucan receptor signaling in
the BMDCs (Fig. 5, a and b). Indeed, similar to our obser-
vations in macrophages overexpressing dectin-1 (Fig. 4),
zymosan depleted of its TLR-stimulating activity, although
a poor inducer of IL-12 in BMDCs alone, is strongly syn-
ergistic with PAM3CSK4 lipopeptide for induction of IL-12
(unpublished data).
In addition to dectin-1, Mac-1 (CD11b) has been sug-
gested to participate in recognition of  -glucans (29).
Therefore, we examined the effect of soluble  -glucan on
zymosan-induced responses in BMDCs from Mac-1–defi-
cient mice. Zymosan-induced IL-12 and TNF-  produc-
tion and inhibition by soluble  -glucan were identical in
Mac-1    and wild-type BMDCs (Fig. 5 c and unpublished
data), suggesting that dectin-1, not Mac-1, is the  -glucan
receptor responsible for the observed modulation of
BMDC responses to zymosan.
Dectin-1 Triggers NADPH Oxidase Activation. Because
zymosan activates the production of ROS in leukocytes
and   -glucan recognition is implicated in the response
(30–32), we examined whether dectin-1 mediates zymo-
san-induced activation of ROS production independent
of its ability to enhance TLR-mediated signaling. Zymo-
Figure 5. TLRs and dectin-1 collaborate in
primary bone marrow dendritic cells. (a) Induc-
tion of cytokines in mouse BMDCs was mea-
sured by ELISA. The cells were stimulated for
4 h with 100  g/ml zymosan or 100 ng/ml
PAM3CSK4 lipopeptide in the presence or ab-
sence of 500  g/ml laminarin. N.D., none de-
tected. (b) Induction of cytokines was measured
by quantitative real-time PCR in primary den-
dritic cells from MyD88     and MyD88   
mice stimulated for 4 h as in a. (c) Induction of
IL-12 p40 was measured by quantitative real-time
PCR in dendritic cells from Mac-1(CD11b)   
mice stimulated as in b.T
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san-induced ROS production in macrophages was inhib-
ited in a dose-dependent manner by laminarin (Fig. 6 a),
indicating that these cells require  -glucan recognition to
trigger ROS production. Similarly, we observed that de-
pleted zymosan strongly activates ROS production in a
laminarin-inhibitable fashion (unpublished data), demon-
strating that TLR activation is not required for ROS pro-
duction. Therefore, we examined the production of ROS
in cells overexpressing dectin-1 and we observed that cells
overexpressing dectin-1 exhibit faster kinetics and greater
magnitude of ROS production in response to zymosan
(Fig. 6 b). The enhanced response was also strongly inhib-
ited by soluble  -glucans (Fig. 6 b). In RAW cell popula-
tions expressing the signaling-deficient Dectin- 38 mu-
tant, zymosan-induced ROS production was reduced
nearly to baseline levels (Fig. 6 c) although particle bind-
ing and internalization were not inhibited (unpublished
data). Taken together, these data demonstrate that  -glu-
can recognition by dectin-1 triggers ROS production. In
addition, these data demonstrate that low level expression
of dectin-1 in RAW cells is responsible for zymosan-induced
ROS production and that the signaling-deficient form of
the receptor acts as a dominant-negative inhibitor of the
endogenous receptor.
It has long been appreciated that TLR stimuli such as
LPS can potentiate inflammatory responses such as ROS
production and arachidonic acid metabolism that are trig-
gered by other receptors (33, 34). Therefore, we examined
whether dectin-1 can trigger inflammatory responses that
are primed but not induced by TLRs. Despite the height-
ened production of ROS in RAW cells overexpressing
dectin-1, ROS production induced by zymosan is still fur-
ther potentiated by prestimulating the cells with the TLR
stimuli LPS or PAM3CSK4 lipopeptide, demonstrating that
TLR activation can prime a response that is triggered by
dectin-1 (Fig. 6 d). Thus, in addition to direct cooperation
between TLR2 and dectin-1 in zymosan recognition and
inflammatory cytokine production, dectin-1 can also coop-
erate with additional TLRs in a sequential manner to in-
duce potent antimicrobial responses.
Discussion
We have identified dectin-1 as an important partner for
TLR2 on macrophages and dendritic cells for the produc-
tion of inflammatory cytokines in response to particulate
stimuli containing  -glucans. Collaboration between dec-
tin-1 and TLR2 in orchestrating immune responses pro-
vides a valuable model for elucidating the mechanisms of
interaction between multiple innate immune recognition
receptors during microbial recognition. During macro-
phage or dendritic cell recognition of zymosan, both dectin-1
and TLR2 are recruited to phagosomes where dectin-1
binds  -glucans and TLR2/CD14 binds distinct compo-
nent(s) of the yeast cell wall yet to be characterized (Fig. 7).
Figure 6. Dectin-1 stimulates production of
ROS in macrophages. (a) Production of ROS
was assayed by luminol-enhanced chemilumi-
nescence in RAW cells in the presence of 100
 g/ml zymosan together with the indicated
concentrations of laminarin. (b) Zymosan-
induced production of ROS in RAW cells was
compared with RAW cells overexpressing
wild-type dectin-1 in the presence or absence
of 500  g/ml laminarin. (c) Zymosan-induced
production of ROS in RAW cells was com-
pared with RAW cells overexpressing a signal-
ing-deficient ( 38) form of dectin-1. (d) Zy-
mosan-induced production of ROS was
measured in RAW cells overexpressing wild-
type dectin-1 with or without 4 h prestimula-
tion with 100 ng/ml LPS or 100 ng/ml
PAM3CSK4 lipopeptide.
Figure 7. Model of dectin-1/TLR collaboration. Zymosan particles
are recognized simultaneously by dectin-1, TLRs, and CD14. Together
these receptors facilitate inflammatory responses to the particle. Dectin-1
directly triggers phagocytosis and stimulates the production of ROS, thus
contributing to microbial killing. TLRs induce signaling through NF- B
that leads to the production of inflammatory cytokines and these re-
sponses are enhanced by dectin-1. Similarly, TLR signaling enhances re-
sponses such as the production of ROS that are triggered by dectin-1.T
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We have demonstrated that dectin-1 ligation results in ty-
rosine phosphorylation of the receptor’s ITAM-like signal-
ing motif, generating intracellular signals that mediate
phagocytosis and activation of the NADPH oxidase, con-
tributing to microbial killing. Many groups have demon-
strated that TLR stimulation leads to activation of NF- B
and production of proinflammatory cytokines such as
TNF-  and IL-12. Using a reconstitution system, macro-
phage cell lines overexpressing dectin-1 and primary den-
dritic cells, we have established that concurrent engage-
ment of dectin-1 enhances these TLR2–mediated
responses. Although it is clear that many receptors partici-
pate in microbial recognition by the innate immune sys-
tem, studies on TLRs as well as on mice deficient in TLR
signaling have surprisingly demonstrated an almost com-
plete requirement for this family of molecules in a broad
range of inflammatory responses. Our data suggest that one
important role of other innate immune recognition recep-
tors (such as dectin-1) in inflammatory gene regulation is to
enhance specific TLR-mediated signaling. Additionally, as
demonstrated by the observation that exposure to LPS or
bacterial lipoproteins primes phagocytes for reactive oxy-
gen production triggered by dectin-1, TLR signaling en-
hances responses triggered by other receptors. Thus, micro-
bial components are directly recognized by both dectin-1
and TLRs and these receptors trigger independent and co-
operative inflammatory responses.
We have demonstrated that signaling through dectin-1
requires tyrosine phosphorylation of an ITAM-like motif.
Although dectin-1 is the first direct innate immune recog-
nition receptor demonstrated to signal through an ITAM-
like motif, these motifs are found in many receptors in-
cluding B and T cell antigen receptors, Fc receptors, and
NK activating receptors. One recent report has suggested
that activation of autoreactive B cells by chromatin–IgG
complexes occurs synergistically through the B cell recep-
tor and a TLR (35). Also, Fc receptor ligation in macro-
phages has been reported to inhibit subsequent induction
of IL-12 by LPS through a mechanism requiring intracel-
lular calcium fluxes (36, 37). We have observed that dectin-1
signaling potentiates IL-12 production by TLR2 stimuli,
suggesting that although dectin-1 triggers phagocytosis like
Fc receptors, important differences in signaling exist. Fc
receptors have been reported to associate with a variety of
other surface molecules including Mac-1, CD9, and lipid
rafts (29, 38, 39), and it is possible that coactivation of sig-
naling through additional receptors participates in the
reported inhibition of LPS-induced IL-12. Alternately,
ITAM-based signaling in Fc receptors and dectin-1 might
be different. The ITAM-like motif in dectin-1 is imper-
fect. Although the consensus ITAM motif consists of two
YXXL/I repeats (40, 41), the membrane distal repeat in
dectin-1 lacks the L/I, which may engage different signal-
ing mechanisms. Nonetheless, as for Fc receptors, tyrosine
phosphorylation of the ITAM-like motif in dectin-1 is re-
quired for receptor function.
Other investigators have recently observed that highly
purified TLR2 stimuli are poor inducers of IL-12 in imma-
ture dendritic cells (42, 43). Pulendran et al. (42) demon-
strated that Escherichia coli LPS (a TLR4 stimulus) activated
IL-12 production by highly purified CD8   mouse den-
dritic cells whereas Porphyromonas gingivalis LPS (a TLR2
stimulus) did not. These authors further demonstrated that
when used as adjuvants, this different profile of responses
caused E. coli LPS to induce a Th1 response whereas P. gin-
givalis induced a more Th2-like response. However, Th1-
type immune responses are critical for defense against many
pathogens that activate innate immunity primarily through
TLR2 such as the fungal pathogen Aspergillus fumigatus (44–
46). Therefore, additional components of the microbes
must contribute to induction of Th1 cytokines such as IL-
12. Our data indicate that dectin-1–mediated recognition
of  -glucans found in many fungi (8, 47–49) may focus
Th1-type responses by enhancing production of IL-12.
Microbial recognition by innate immune cells occurs
through multiple receptors including TLRs and lectins, and
the inflammatory consequence of this recognition is depen-
dent on both the repertoire of receptors that are expressed
and functional cooperation between the signals generated
downstream of receptor activation. These interactions
shape the cytokine response and antimicrobial functions of
the cell, and tailor the immune response to be effective
against specific pathogens. In this context, we have ob-
served that dectin-1 collaborates with TLRs in promoting
responses associated with Th1 immunity including produc-
tion of IL-12 and activation of antimicrobial killing (ROS).
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